Atrial Fibrillation and Cardio-Kidney-Metabolic Risk: A Systemic Challenge
A new analysis highlights the complex interplay of cardio-kidney-metabolic (CKM) risk factors in patients with atrial fibrillation, underscoring the need for integrated care models. The study points to significant policy and reimbursement challenges in establishing multidisciplinary CKM clinics.
SGLT2 Inhibitors Post-Heart Transplant: What the Data Show
A 2026 meta-analysis examines SGLT2 inhibitor use in diabetic heart transplant recipients, a population where evidence has been thin and stakes are high.
Atrial Fibrillation Complexity: How Reliable is Registry Data?
Patients with atrial fibrillation often present with a complex interplay of cardio-kidney-metabolic conditions, but large registry data can oversimplify these interactions. Clinicians should interpret such observational findings cautiously, especially when considering individual patient management.
Lorlatinib and the Enigma of Autoantibody-Negative Diabetes
Patients on lorlatinib may develop diabetes with unusual characteristics, including the absence of typical autoantibodies. This presents a diagnostic challenge, requiring clinicians to consider drug-induced etiologies even when initial immunological markers are negative.
Opportunistic Osteoporosis Screening from CT Scans A Validated Approach?
Using cranial CT scans for opportunistic osteoporosis screening shows promise, but concerns remain. Addressing methodological criticisms is essential for validating this approach in broader clinical practice.
